The re-import of composite diagnostic or laboratory reagents to China is projected to increase steadily from 2024 to 2028, starting at 9.54 thousand kilograms and reaching 11.13 thousand kilograms. Compared to an actual volume of 9.1 thousand kilograms in 2023, this reflects a continuous annual growth with a CAGR of approximately 4% over the five-year forecast period. The consistent rise suggests a growing demand for these reagents due to advancements in medical diagnostics and laboratory technologies in China.
Future trends to watch for:
- Technological innovations driving demand increases for high-grade reagents.
- Policies supporting domestic production that may influence re-import volumes.
- Global supply chain dynamics affecting importation costs or availability.
- Potential growth in China's healthcare and diagnostics sector contributing to increased reagent needs.
